Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-21-000043
Filing Date
2021-01-08
Accepted
2021-01-08 17:19:57
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 a2242789z424b4.htm 424B4 3656880
2 G78618.JPG g78618.jpg GRAPHIC 12150
3 G525063.JPG g525063.jpg GRAPHIC 41539
4 G391661.JPG g391661.jpg GRAPHIC 28908
5 G777169.JPG g777169.jpg GRAPHIC 45767
6 G816446.JPG g816446.jpg GRAPHIC 48524
7 G519042.JPG g519042.jpg GRAPHIC 51354
8 G614550.JPG g614550.jpg GRAPHIC 44053
9 G436008.JPG g436008.jpg GRAPHIC 31304
10 G985939.JPG g985939.jpg GRAPHIC 37998
11 G781255.JPG g781255.jpg GRAPHIC 31682
12 G528564.JPG g528564.jpg GRAPHIC 42149
13 G994530.JPG g994530.jpg GRAPHIC 81346
14 G928278.JPG g928278.jpg GRAPHIC 85755
15 G451675.JPG g451675.jpg GRAPHIC 33376
16 G347127.JPG g347127.jpg GRAPHIC 14439
  Complete submission text file 0001047469-21-000043.txt   4528013
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000
Type: 424B4 | Act: 33 | File No.: 333-251322 | Film No.: 21518372
SIC: 2834 Pharmaceutical Preparations